Report: Canadian biotechs heading for "significant consolidation"

Ernst & Young, which reported on the U.S. biotechnology industry outlook earlier this week, also looked at the Canadian industry and said it expects "significant industry consolidation" to take place this year. The Canadian industry lags behind its U.S. counterparts because it is dominated by small, undercapitalized firms, which nevertheless posted a 21% gain in revenues in 2004 over the previous year.

View Full Article in:

Globe and Mail (Toronto) (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ